Re: Axillary Lymph Node Staging in Breast Cancer by 2-Fluoro-2-deoxy-D-glucose-Positron Emission Tomography: Clinical Evaluation and Alternative Management
Open Access
- 7 November 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 93 (21) , 1659-1660
- https://doi.org/10.1093/jnci/93.21.1659
Abstract
Greco et al. (1) reported that 2-fluoro-2-deoxy-d-glucose–positron emission tomography (FDG–PET) is a reliable and accurate method to predict the axillary status in breast cancers of 1–2 cm in diameter: Histopathology detected axillary lymph node (ALN) metastases in 72 (43%) of 167 patients, and 68 ALN metastases were detected by PET (sensitivity = 94.4%).Keywords
This publication has 6 references indexed in Scilit:
- Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistryJournal of Clinical Pathology, 2001
- Axillary Lymph Node Staging in Breast Cancer by 2-Fluoro-2-deoxy-D-glucose-Positron Emission Tomography: Clinical Evaluation and Alternative ManagementJNCI Journal of the National Cancer Institute, 2001
- Immunohistochemical detection of lymph-node metastasesThe Lancet, 2000
- Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up.Journal of Clinical Pathology, 1999
- The Sentinel node in breast cancer: implications for adjuvant treatment?European Journal of Nuclear Medicine and Molecular Imaging, 1999
- Herbal remedies—an alternativeThe Lancet, 1990